FtsZ inhibitor (Daiichi Sankyo)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFtsZ inhibitor (Daiichi Sankyo)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial FtsZ proteins inhibitors
TargetsBacterial FtsZ proteins
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A